GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
61.13
+1.23 (2.05%)
At close: Jun 3, 2026, 4:00 PM EDT
59.91
-1.22 (-2.00%)
After-hours: Jun 3, 2026, 4:07 PM EDT
GRAIL Employees
GRAIL had 910 employees as of December 31, 2025. The number of employees decreased by 90 or -9.00% compared to the previous year.
Employees
910
Change (1Y)
-90
Growth (1Y)
-9.00%
Revenue / Employee
$171,560
Profits / Employee
-$434,423
Market Cap
2.62B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 910 | -90 | -9.00% |
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Sep 30, 2024 | 1,170 | -190 | -13.97% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| CareDx | 765 |
| Veracyte | 755 |
GRAL News
- 8 hours ago - GRAIL Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 days ago - GRAIL Transcript: Study result - Transcripts
- 2 days ago - GRAIL Press release: Study result - Filings
- 3 days ago - GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting - PRNewsWire
- 4 days ago - GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting - PRNewsWire
- 7 days ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 8 days ago - GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - PRNewsWire
- 13 days ago - GRAIL to Present at the 2026 Jefferies Global Healthcare Conference - PRNewsWire